Adaptive Biotechnologies Corp vs Utilities Select Sector SPDR Fund — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Utilities Select Sector SPDR Fund trades at $43.64. The key difference: Adaptive Biotechnologies Corp is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| ADPT | XLU | |
|---|---|---|
Market Cap | $4.04B | — |
Sector | Health | — |
52-Week High | $25.45 | $47.73 |
52-Week Low | $12.30 | $41.31 |
Enterprise Value | $4.10B | — |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →